Enhancing studies of the connectome in autism using the autism brain imaging data exchange II.
Di Martino A, O'Connor D, Chen B, Alaerts K, Anderson JS, Assaf M, Balsters JH, Baxter L, Beggiato A, Bernaerts S, Blanken LM, Bookheimer SY, Braden BB, Byrge L, Castellanos FX, Dapretto M, Delorme R, Fair DA, Fishman I, Fitzgerald J, Gallagher L, Keehn RJ, Kennedy DP, Lainhart JE, Luna B, Mostofsky SH, Müller RA, Nebel MB, Nigg JT, O'Hearn K, Solomon M, Toro R, Vaidya CJ, Wenderoth N, White T, Craddock RC, Lord C, Leventhal B, Milham MP. · 2017
Read Enhancing studies of the connectome in autism using the autism brain imaging data exchange II. by Di Martino A, O'Connor D, Chen B, Alaerts K, Anderson JS, Assaf M, Balsters JH, Baxter L, Beggiato A, Bernaerts S, Blanken LM, Bookheimer SY, Braden BB, Byrge L, Castellanos FX, Dapretto M, Delorme R, Fair DA, Fishman I, Fitzgerald J, Gallagher L, Keehn RJ, Kennedy DP, Lainhart JE, Luna B, Mostofsky SH, Müller RA, Nebel MB, Nigg JT, O'Hearn K, Solomon M, Toro R, Vaidya CJ, Wenderoth N, White T, Craddock RC, Lord C, Leventhal B, Milham MP. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5349246.txt.
Introduction
Adriana Di Martino led a large team in sharing a second wave of autism brain scans in Scientific Data in 2017. Autism research needs large, open data sets to find firm patterns in brain wiring. The first exchange of this kind gave out more than a thousand data sets in 2012. That scale let labs test claims on shared ground rather than on small home sets.
The new wave adds scans from close to five hundred people with autism and more than five hundred controls, gathered at sixteen sites across the world. Each set joins resting brain scans with body scans and rich notes on traits and health. Joined with the first wave, the store holds more than two thousand full sets. Some sets add diffusion scans that trace wiring paths. The size can help split autism into true subtypes and probe sex gaps.
Catalog record
| CREATOR | Di Martino A, O'Connor D, Chen B, Alaerts K, Anderson JS, Assaf M, Balsters JH, Baxter L, Beggiato A, Bernaerts S, Blanken LM, Bookheimer SY, Braden BB, Byrge L, Castellanos FX, Dapretto M, Delorme R, Fair DA, Fishman I, Fitzgerald J, Gallagher L, Keehn RJ, Kennedy DP, Lainhart JE, Luna B, Mostofsky SH, Müller RA, Nebel MB, Nigg JT, O'Hearn K, Solomon M, Toro R, Vaidya CJ, Wenderoth N, White T, Craddock RC, Lord C, Leventhal B, Milham MP. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Enhancing studies of the connectome in autism using the autism brain imaging data exchange II By Adriana Di Martino, David O’Connor, Bosi Chen, Kaat Alaerts, Jeffrey S. Anderson, Michal Assaf, Joshua H. Balsters, Leslie Baxter, Anita Beggiato, Sylvie Bernaerts, Laura M. E. Blanken, Susan Y. Bookheimer Published in: Scientific Data DOI: 10.1038/sdata.2017.10 ABSTRACT The second iteration of the Autism Brain Imaging Data Exchange (ABIDE II) aims to enhance the scope of brain connectomics research in Autism Spectrum Disorder (ASD). Consistent with the initial ABIDE effort (ABIDE I), that released 1112 datasets in 2012, this new multisite open-data resource is an aggregate of resting state functional magnetic resonance imaging (MRI) and corresponding structural MRI and phenotypic datasets. ABIDE II includes datasets from an additional 487 individuals with ASD and 557 controls previously collected across 16 international institutions. The combination of ABIDE I and ABIDE II provides investigators with 2156 unique cross-sectional datasets allowing selection of samples for discovery and/or replication. This sample size can also facilitate the identification of neurobiological subgroups, as well as preliminary examinations of sex differences in ASD. Additionally, ABIDE II includes a range of psychiatric variables to inform our understanding of the neural correlates of co-occurring psychopathology; 284 diffusion imaging datasets are also included. It is anticipated that these enhancements will contribute to unraveling key sources of ASD heterogeneity. BACKGROUND & SUMMARY Multiple sources of evidence have substantiated models of abnormal neural connectivity in autism spectrum disorder (ASD) 1–5 . At the macroscale, abnormal connections among brain regions have been revealed by functional and structural neuroimaging in children, adolescents and, adults with ASD 1,6–9 . Yet, both the complexity of the brain connectome 10,11 and the striking heterogeneity of ASD 12–16 have hampered efforts to specify the nature of putative dysconnections. In response, open-data sharing is increasingly being encouraged to rapidly amass the large-scale datasets needed to confront heterogeneity, engage a broader range of scientific disciplines, and facilitate independent replications 17–21 . To bring the open data sharing model to autism neuroimaging, the Autism Brain Imaging Data Exchange (ABIDE) 22 was launched in 2012. The initial ABIDE initiative—now termed ABIDE I—was the first open-access brain imaging repository of resting state functional magnetic resonance imaging (R-fMRI) and corresponding structural data of individuals with ASD and typical controls (N=539 and 573, respectively) aggregated from multiple international institutions. Here, we introduce ABIDE II (Data Citation 1), a new multi-site open data resource containing 1,044 independent datasets (ASD N=487; Controls N=557) created to enhance the significance of the questions that can be addressed regarding the neural correlates of ASD and accelerate the pace of discovery. The initial ABIDE I effort established the feasibility of aggregating multisite data without prior harmonization, leading to more than 55 peer-reviewed studies in the 48 months since inception. Despite its success, ABIDE I is limited in regard to sample characterization and sample size. Specifically, despite containing more than 1,000 datasets, ABIDE I was not sufficiently large to furnish optimally sized discovery and replication subsamples. By combining the ABIDE I and ABIDE II data resources, investigators can select larger samples for discovery and replication, depending on their investigative endeavors. Replication samples are needed to minimize false positives and avoid settling for ‘approximate replications’ 19 —a practice that has plagued biological psychiatry 19 and neuroscience more broadly 17 . Additionally, as recently demonstrated, the utility of datasets for prediction increases with sample size—even if heterogeneous data sources are used to amass large samples 23 . Along with increased sample size, ABIDE II provides greater phenotypic characterization than was available across the ABIDE I data collections to better address two key sources of heterogeneity. The first is psychopathology co-occurring with ASD, which has been largely overlooked in the imaging literature 15,16,24 . Accordingly, ABIDE II actively encouraged investigators to provide phenotypic information regarding co-occurring illness, if assessed. The second source of heterogeneity is driven by sex-related differences. These have been generally ignored in the ASD imaging literature due to the markedly higher prevalence of males with ASD and the tendency of single sites to exclude or minimally represent females. The ABIDE II sample has increased the number of available datasets from females with ASD from 65 in ABIDE I to 138 when ABIDE I+II are combined. We believe these enhancements will allow investigators to more directly investigate pathophysiology specific to ASD, to potentially identify neurobiological subgroups and facilitate the identification of protective and risk factors. Finally, beyond its focus on intrinsic functional connectivity and other indices of intrinsic brain function, ABIDE II now includes a subset of datasets (N=284) with diffusion-weighted images. In order to facilitate immediate access and use of ABIDE II, the methods utilized to generate this resource, the resulting currently available data and their technical validation are described below. METHODS Criteria for data contributions We solicited investigators willing and able to openly share their previously collected awake R-fMRI data of individuals with ASD and controls, along with corresponding high-resolution anatomical images and phenotypic information. Contributions have been sought from all charter ABIDE I members and invitations are extended to any other investigators involved in ASD neuroimaging. The present work includes information regarding all contributions received prior to June 24, 2016. Contributions will continue to be accepted up to December 2016. Contributors are encouraged to share at least 20 unique datasets per diagnostic group (i.e., ASD and controls). Data collections of only individuals with ASD are also accepted as they can be utilized for data-driven explorations addressing heterogeneity e.g., refs 25,26. Consistent with prior FCP/INDI efforts 27 , investigators are also encouraged to contribute nearly all MRI datasets, without a priori quality criteria (see Technical Validation for quality assessment (QA) measures incorporated into ABIDE II). The availability of minimal phenotypic information essential for data analyses and sample characterization (i.e., diagnostic classification, age, sex) is required for contribution. To enhance phenotypic characterization, sharing of additional measures commonly used in ASD research, information on psychiatric comorbidity, medication status, cognition and/or language are highly encouraged. Similarly, to enhance the breath of investigations about the ASD connectome, whenever available, contributions of corresponding diffusion images for each individual are welcome for aggregation. Finally, prior to data contribution, sites are required to confirm that their local Institutional Review Board (IRB) or ethics committee have approved both the initial data collection and the retrospective sharing of a fully de-identified version of the datasets (i.e., after removal of the 18 protected health information identifiers including facial information from structural images as identified by the Health Insurance Portable and Accountability Act [HIPAA]). Of note, two institutions provided longitudinal MRI scans from subsets of individuals’ datasets (n=23 ASD and n=15 controls) previously contributed to ABIDE I. Given the relevance of developmental changes 28–32 , these datasets are also included in the ABIDE II. To distinguish them from the cross-sectional aggregates, these datasets are organized into a separate set of collections focused on longitudinal data using the original ABIDE I IDs. Data preparation and aggregation Prior to contribution, each institution is asked to rename all data by replacing local subject identification numbers with FCP/INDI identifiers. They are also asked to remove personally identifying information (PHI) including those from images (e.g., NIFTI headers and face information from any high-resolution